USANA Operating Cycle from 2010 to 2026
| USNA Stock | USD 20.55 1.55 8.16% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 186.465258 | Current Value 121.28727109 | Quarterly Volatility 25.28855893 |
Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 884.1 K, Total Revenue of 610.5 M or Gross Profit of 492 M, as well as many indicators such as Price To Sales Ratio of 1.12, Dividend Yield of 0.0 or PTB Ratio of 2.08. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
USANA | Operating Cycle | Build AI portfolio with USANA Stock |
Analyzing USANA Health's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing USANA Health's current valuation and future prospects.
Latest USANA Health's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of USANA Health Sciences over the last few years. It is USANA Health's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in USANA Health's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
USANA Operating Cycle Regression Statistics
| Arithmetic Mean | 140.26 | |
| Geometric Mean | 138.29 | |
| Coefficient Of Variation | 18.03 | |
| Mean Deviation | 20.48 | |
| Median | 128.33 | |
| Standard Deviation | 25.29 | |
| Sample Variance | 639.51 | |
| Range | 74.9889 | |
| R-Value | 0.19 | |
| Mean Square Error | 657.25 | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | 0.96 | |
| Total Sum of Squares | 10,232 |
USANA Operating Cycle History
About USANA Health Financial Statements
USANA Health stakeholders use historical fundamental indicators, such as USANA Health's Operating Cycle, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 186.47 | 121.29 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out the analysis of USANA Health Correlation against competitors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive USANA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.04) | Earnings Share 0.9 | Revenue Per Share | Quarterly Revenue Growth 0.067 | Return On Assets |
Understanding USANA Health Sciences requires distinguishing between market price and book value, where the latter reflects USANA's accounting equity. The concept of intrinsic value - what USANA Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push USANA Health's price substantially above or below its fundamental value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, USANA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.